Presentation TVT 2021 Predictions on Late TAVR Failure Modes: Management Strategies and Innovation Opportunities Presenter: Tsuyoshi Kaneko July 21, 2021
Presentation TVT 2021 Trans-Septal ViMAC Approach, Devices, and Outcomes Presenter: Mayra Guerrero July 21, 2021
Presentation TVT 2021 Trans-Atrial ViMAC Approach, Devices and Outcomes Presenter: Isaac George July 21, 2021
Presentation TVT 2021 Trans-Femoral Systems: Landscape of Devices and Early Clinical Outcomes Presenter: Howard Herrmann July 21, 2021
Presentation TVT 2021 Chordal Replacement and Other Technologies Presenter: Mayra Guerrero July 21, 2021
Presentation TVT 2021 First Report of 2-Year Outcomes With a Next-Generation Left Atrial Appendage Closure Device: Final Results From the PINNACLE FLX IDE Trial Presenter: Saibal Kar July 21, 2021
Presentation TVT 2021 Case Resolution: LVOT Obstruction After Mitral ViMAC Presenter: Mayra Guerrero July 20, 2021
Presentation TVT 2021 Case Introduction: LVOT Obstruction After Mitral ViMAC Presenter: Mayra Guerrero July 20, 2021
Presentation TVT 2021 Case Resolution: Late Symptomatic Mitral Stenosis After TEER Presenter: Adam Greenbaum July 20, 2021
Presentation TVT 2021 Case Introduction: Late Symptomatic Mitral Stenosis After TEER Presenter: Adam Greenbaum July 20, 2021
Presentation TVT 2021 Case Resolution: Residual ASD After TEER Presenter: Howard Herrmann July 20, 2021
Presentation TVT 2021 Case Introduction: Residual ASD After TEER Presenter: Howard Herrmann July 20, 2021
News Conference News TVT 2021 TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year Todd Neale July 20, 2021
Presentation TVT 2021 TEER Device Evolution: Impact on Technical Success and Complications Presenter: Anita Asgar July 20, 2021
News Conference News TVT 2020 Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform Yael L. Maxwell June 26, 2020
News Conference News TVT 2020 Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear Todd Neale June 25, 2020
News Conference News TVT 2020 Device Explants After TAVR Rare but Risky Michael O'Riordan June 24, 2020
News Conference News TVT 2020 Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO Shelley Wood June 24, 2020
News Conference News TVT 2020 Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events Michael O'Riordan June 23, 2020